GF-^|^beta;and HGF Transmit the Signals through JNK-Dependent Smad3 Phosphorylation at the Linker Regions

No abstract is available for this paper.

• Publication year

  2005

• Venue

  The journal of Kansai Medical University

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.5361/JKMU1956.57.2-4_188
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Smad transcription factors as mediators of 7 transmembrane G protein-coupled receptor signalling

  2024cites this paper
• Intricacies of TGF-β signaling in Treg and Th17 cell biology

  2023cites this paper
• Advances in targeting the extracellular matrix for glaucoma therapy: current updates

  2023cites this paper
• Overexpression of Hepatocyte Growth Factor in Dental Pulp Stem Cells Ameliorates the Severity of Psoriasis by Reducing Inflammatory Responses

  2021cites this paper
• Linker Threonine-phosphorylated Smad2/3 Is a Biomarker of Colorectal Neoplastic Stem-like Cells that Correlates With Carcinogenesis

  2021cites this paper
• Specific Smad2/3 Linker Phosphorylation Indicates Esophageal Non-neoplastic and Neoplastic Stem-Like Cells and Neoplastic Development

  2020cites this paper
• Long-term model of colitis-associated colorectal cancer suggests tumor spread mechanism and nature of cancer stem cells.

  2020cites this paper
• Involvement of the JNK signaling in granular corneal dystrophy by modulating TGF-β-induced TGFBI expression and corneal fibroblast apoptosis

  2020cites this paper
• Regulation of tumor angiogenesis and mesenchymal–endothelial transition by p38α through TGF-β and JNK signaling

  2019cites this paper
• GPCR transactivation signalling in vascular smooth muscle cells: role of NADPH oxidases and reactive oxygen species

  2019cites this paper
• Clinico-Pathological Importance of TGF-β/Phospho-Smad Signaling during Human Hepatic Fibrocarcinogenesis

  2018cites this paper
• Mitogen-activated protein kinase inhibitors reduce the nuclear accumulation of phosphorylated Smads by inhibiting Imp 7 or Imp 8 in HepG2 cells

  2018cites this paper
• G protein coupled receptors can transduce signals through carboxy terminal and linker region phosphorylation of Smad transcription factors

  2018cites this paper
• Crosstalk between mitogen-activated protein kinase inhibitors and transforming growth factor-β signaling results in variable activation of human dermal fibroblasts

  2018cites this paper
• The role of TGFβ-HGF-Smad4 axis in regulating the proliferation of mouse airway progenitor cells

  2017cites this paper
• Identification of Tisp40 as an Essential Regulator of Renal Tubulointerstitial Fibrosis via TGF-β/Smads Pathway

  2017cites this paper
• Carcinogenic and stem cell-like phenotypes of Smad2/3 linker phosphorylation in a mouse model of colitis-associated colorectal cancer

  2017cites this paper
• Nuclear movement regulated by non-Smad Nodal signaling via JNK is associated with Smad signaling during zebrafish endoderm specification

  2017cites this paper
• Bone Morphogenetic Protein-9 Enhances Osteogenic Differentiation of Human Periodontal Ligament Stem Cells via the JNK Pathway

  2017cites this paper
• Molecular Pathways: Cachexia Signaling—A Targeted Approach to Cancer Treatment

  2016cites this paper
• JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships

  2016cites this paper
• Deregulated E2F5/p38/SMAD3 Circuitry Reinforces the Pro‐Tumorigenic Switch of TGFβ Signaling in Prostate Cancer

  2016cites this paper
• IL-37 suppresses hepatocellular carcinoma growth by converting pSmad3 signaling from JNK/pSmad3L/c-Myc oncogenic signaling to pSmad3C/P21 tumor-suppressive signaling

  2016cites this paper
• Smad2/3 linker phosphorylation is a possible marker of cancer stem cells and correlates with carcinogenesis in a mouse model of colitis-associated colorectal cancer.

  2015cites this paper
• c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma

  2015cites this paper
• The Smad3/Smad4/CDK9 complex promotes renal fibrosis in mice with unilateral ureteral obstruction.

  2015cites this paper
• Retinoic acid promotes myogenesis in myoblasts by antagonizing transforming growth factor-beta signaling via C/EBPβ

  2015cites this paper
• Axl activates autocrine transforming growth factor‐β signaling in hepatocellular carcinoma

  2015cites this paper
• Atherogenic, fibrotic and glucose utilising actions of glucokinase activators on vascular endothelium and smooth muscle

  2014cites this paper
• Smad3 phospho-isoform signaling in hepatitis C virus-related chronic liver diseases.

  2014cites this paper
• Reversible phospho‐Smad3 signalling between tumour suppression and fibrocarcinogenesis in chronic hepatitis B infection

  2014cites this paper
• Linker phosphorylation of Smad3 promotes fibro-carcinogenesis in chronic viral hepatitis of hepatocellular carcinoma.

  2014cites this paper
• Transforming growth factor β‐mediated site‐specific Smad linker region phosphorylation in vascular endothelial cells

  2014cites this paper
• TGF-β Mediated Crosstalk Between Malignant Hepatocyte and Tumor Microenvironment in Hepatocellular Carcinoma

  2014cites this paper
• Molecular aspects of development and regulation of endometriosis

  2014influential citation
• TGF-β/Smad signaling during hepatic fibro-carcinogenesis (Review)

  2014cites this paper
• Ursodeoxycholyl lysophosphatidylethanolamide attenuates hepatofibrogenesis by impairment of TGF‐β1/Smad2/3 signalling

  2014cites this paper
• The Role of Intercellular Contacts in EpithelialL-mesenchymal/-myofibroblast Transition

  2013influential citation
• Regulation der TGFβ Signaltransduktion durch Phosphorylierung des Transkriptions-Cofaktors Smif

  2013cites this paper
• Insights into the Transforming Growth Factor-β Signaling Pathway in Cutaneous Melanoma

  2013cites this paper
• Cell biology of Smad2/3 linker region phosphorylation in vascular smooth muscle

  2012cites this paper
• Non-Canonical Smads Phosphorylation Induced by the Glutamate Release Inhibitor, Riluzole, through GSK3 Activation in Melanoma

  2012cites this paper
• A Crosstalk between the Smad and JNK Signaling in the TGF-β-Induced Epithelial-Mesenchymal Transition in Rat Peritoneal Mesothelial Cells

  2012cites this paper
• TGF-β enhances deposition of perlecan from COPD airway smooth muscle.

  2012cites this paper
• The specific linker phosphorylation of Smad2/3 indicates epithelial stem cells in stomach; particularly increasing in mucosae of Helicobacter-associated gastritis

  2011influential citation
• Regulation of TGF-β1-Induced Pro-Apoptotic Signaling by Growth Factor Receptors and Extracellular Matrix Receptor Integrins in the Liver

  2011cites this paper
• TGF-β stimulates biglycan core protein synthesis but not glycosaminoglycan chain elongation via Akt phosphorylation in vascular smooth muscle

  2011cites this paper
• Constitutive Smad linker phosphorylation in melanoma: a mechanism of resistance to transforming growth factor‐β‐mediated growth inhibition

  2011cites this paper
• TGF-β stimulates biglycan synthesis via p38 and ERK phosphorylation of the linker region of Smad2

  2010cites this paper
• Resistance to transforming growth factor β-mediated tumor suppression in melanoma: are multiple mechanisms in place?

  2010cites this paper
• Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor‐β/Smad in HepG2 cell

  2010cites this paper
• Growth differentiation factor 9 signaling requires ERK1/2 activity in mouse granulosa and cumulus cells

  2010cites this paper
• The crosstalk of RAS with the TGF-β family during carcinoma progression and its implications for targeted cancer therapy.

  2010cites this paper
• Modulation of TGF-beta signaling during progression of chronic liver diseases.

  2009influential citation
• JNK1, a potential therapeutic target for hepatocellular carcinoma.

  2009cites this paper
• Role of the Type III TGF-beta Receptor Cytoplasmic Domain in Breast Cancer Progression

  2009cites this paper
• HGF as a multifunctional anti-fibrotic agent with high impact on gene therapy for renal interstitial fibrosis

  2009cites this paper
• Mitogen activated protein kinases in renal fibrosis.

  2009influential citation
• c-Jun N-terminal kinase 1 is required for the development of pulmonary fibrosis.

  2009cites this paper
• Effects of 1, 25(OH) 2 D 3 on Smad2 Activity in PC-3 Pr ostate C ancer Cel ls

  2009cites this paper
• Transforming Growth Factor β1 Induces Epithelial–mesenchymal Transition by Activating the Jnk–SMAD3 Pathway in Rat Peritoneal Mesothelial Cells

  2008cites this paper
• Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-β1

  2008influential citation
• Role of mitogen-activated protein kinase kinase 4 in cancer

  2007cites this paper
• Upregulation of the TGFβ signalling pathway by Bcr‐Abl: Implications for haemopoietic cell growth and chronic myeloid leukaemia

  2007cites this paper
• Glutathione suppresses TGF-beta-induced PAI-1 expression by inhibiting p38 and JNK MAPK and the binding of AP-1, SP-1, and Smad to the PAI-1 promoter.

  2007cites this paper
• Upregulation of the TGFb signalling pathway by Bcr-Abl: Implications for haemopoietic cell growth and chronic myeloid leukaemia

  2007cites this paper
• Activation of Transforming Growth Factor‐β1/p38/Smad3 Signaling in Stromal Cells Requires Reactive Oxygen Species–Mediated MMP‐2 Activity During Bone Marrow Damage

  2005cites this paper
• Characterization of a novel transcriptionally active domain in the transforming growth factor β-regulated Smad3 protein

  2005cites this paper